The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.
- First select the CSR Section, then a Table/Figure from that section.
- Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.
To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR(PDF, 524KB) and Technical Notes(PDF, 752KB) pages.
Download and Print: Download Printer-friendly PDF Download data
Figure 18.3
Figure 18.3
SEER Observed Incidence and SEER Delay Adjusted Incidence Rates a
SEER 9 Areas Compared to SEER 13 Areas
Myeloma, Male, by Race
Rates per 100,000 for Myeloma, All Races, Male, All Ages
| Year | Delay-Adjusted SEER 9 Incidence 1975-2015 | Delay-Adjusted SEER 9 Incidence 1975-2015 Modeled (from Joinpoint) | Observed SEER 9 Incidence 1975-2015 | Observed SEER 9 Incidence 1975-2015 Modeled (from Joinpoint) | Delay-Adjusted SEER 13 Incidence 1992-2015 | Delay-Adjusted SEER 13 Incidence 1992-2015 Modeled (from Joinpoint) | Observed SEER 13 Incidence 1992-2015 | Observed SEER 13 Incidence 1992-2015 Modeled (from Joinpoint) |
|---|---|---|---|---|---|---|---|---|
| 1975 | 6.4 | 6.1 | 6.4 | 6.0 | ||||
| 1976 | 6.1 | 6.2 | 6.1 | 6.1 | ||||
| 1977 | 6.4 | 6.2 | 6.4 | 6.1 | ||||
| 1978 | 5.9 | 6.3 | 5.9 | 6.2 | ||||
| 1979 | 6.0 | 6.3 | 6.0 | 6.2 | ||||
| 1980 | 5.8 | 6.4 | 5.8 | 6.3 | ||||
| 1981 | 6.0 | 6.4 | 6.0 | 6.4 | ||||
| 1982 | 6.3 | 6.5 | 6.3 | 6.4 | ||||
| 1983 | 6.9 | 6.5 | 6.9 | 6.5 | ||||
| 1984 | 7.0 | 6.6 | 7.0 | 6.5 | ||||
| 1985 | 6.3 | 6.6 | 6.3 | 6.6 | ||||
| 1986 | 6.3 | 6.7 | 6.3 | 6.7 | ||||
| 1987 | 7.4 | 6.7 | 7.4 | 6.7 | ||||
| 1988 | 6.6 | 6.8 | 6.6 | 6.8 | ||||
| 1989 | 6.7 | 6.8 | 6.7 | 6.8 | ||||
| 1990 | 7.3 | 6.9 | 7.3 | 6.9 | ||||
| 1991 | 7.7 | 7.0 | 7.7 | 7.0 | ||||
| 1992 | 7.3 | 7.0 | 7.3 | 7.0 | 7.3 | 7.1 | 7.3 | 7.1 |
| 1993 | 7.3 | 7.1 | 7.3 | 7.1 | 7.3 | 7.1 | 7.3 | 7.1 |
| 1994 | 6.8 | 7.1 | 6.8 | 7.2 | 6.9 | 7.2 | 6.9 | 7.2 |
| 1995 | 7.2 | 7.2 | 7.2 | 7.2 | 6.9 | 7.2 | 6.9 | 7.2 |
| 1996 | 7.2 | 7.2 | 7.2 | 7.3 | 7.4 | 7.2 | 7.4 | 7.2 |
| 1997 | 7.4 | 7.3 | 7.4 | 7.4 | 7.5 | 7.2 | 7.5 | 7.2 |
| 1998 | 7.4 | 7.4 | 7.4 | 7.4 | 7.2 | 7.3 | 7.2 | 7.3 |
| 1999 | 7.1 | 7.4 | 7.1 | 7.5 | 7.1 | 7.3 | 7.1 | 7.3 |
| 2000 | 7.7 | 7.5 | 7.7 | 7.6 | 7.4 | 7.3 | 7.4 | 7.3 |
| 2001 | 7.4 | 7.5 | 7.4 | 7.6 | 7.1 | 7.3 | 7.1 | 7.3 |
| 2002 | 7.9 | 7.6 | 7.9 | 7.7 | 7.6 | 7.4 | 7.6 | 7.4 |
| 2003 | 7.4 | 7.7 | 7.4 | 7.8 | 7.4 | 7.4 | 7.4 | 7.4 |
| 2004 | 7.5 | 7.7 | 7.5 | 7.9 | 7.5 | 7.4 | 7.5 | 7.4 |
| 2005 | 7.9 | 7.8 | 7.9 | 7.9 | 7.7 | 7.6 | 7.7 | 7.4 |
| 2006 | 7.3 | 7.8 | 7.3 | 8.0 | 7.2 | 7.7 | 7.2 | 7.5 |
| 2007 | 8.1 | 8.0 | 8.0 | 8.1 | 7.9 | 7.9 | 7.8 | 7.7 |
| 2008 | 8.1 | 8.2 | 8.0 | 8.2 | 7.9 | 8.0 | 7.8 | 8.0 |
| 2009 | 8.6 | 8.4 | 8.4 | 8.2 | 8.4 | 8.2 | 8.2 | 8.2 |
| 2010 | 8.8 | 8.6 | 8.6 | 8.3 | 8.6 | 8.3 | 8.4 | 8.5 |
| 2011 | 8.9 | 8.8 | 8.6 | 8.4 | 8.6 | 8.5 | 8.3 | 8.4 |
| 2012 | 9.0 | 8.9 | 8.7 | 8.5 | 8.8 | 8.6 | 8.5 | 8.4 |
| 2013 | 9.3 | 9.1 | 8.9 | 8.5 | 9.0 | 8.8 | 8.6 | 8.3 |
| 2014 | 9.0 | 9.3 | 8.5 | 8.6 | 8.7 | 9.0 | 8.1 | 8.3 |
| 2015 | 9.5 | 9.6 | 8.7 | 8.7 | 9.0 | 9.1 | 8.2 | 8.2 |
Rates per 100,000 for Myeloma, White, Male, All Ages
| Year | Delay-Adjusted SEER 9 Incidence 1975-2015 | Delay-Adjusted SEER 9 Incidence 1975-2015 Modeled (from Joinpoint) | Observed SEER 9 Incidence 1975-2015 | Observed SEER 9 Incidence 1975-2015 Modeled (from Joinpoint) | Delay-Adjusted SEER 13 Incidence 1992-2015 | Delay-Adjusted SEER 13 Incidence 1992-2015 Modeled (from Joinpoint) | Observed SEER 13 Incidence 1992-2015 | Observed SEER 13 Incidence 1992-2015 Modeled (from Joinpoint) |
|---|---|---|---|---|---|---|---|---|
| 1975 | 6.2 | 5.7 | 6.2 | 5.7 | ||||
| 1976 | 5.8 | 5.8 | 5.8 | 5.8 | ||||
| 1977 | 6.2 | 5.8 | 6.2 | 5.8 | ||||
| 1978 | 5.6 | 5.9 | 5.6 | 5.9 | ||||
| 1979 | 5.4 | 5.9 | 5.4 | 5.9 | ||||
| 1980 | 5.4 | 6.0 | 5.4 | 6.0 | ||||
| 1981 | 5.5 | 6.1 | 5.5 | 6.0 | ||||
| 1982 | 5.9 | 6.1 | 5.9 | 6.1 | ||||
| 1983 | 6.3 | 6.2 | 6.3 | 6.1 | ||||
| 1984 | 6.4 | 6.2 | 6.4 | 6.2 | ||||
| 1985 | 6.0 | 6.3 | 6.0 | 6.2 | ||||
| 1986 | 6.0 | 6.3 | 6.0 | 6.3 | ||||
| 1987 | 7.2 | 6.4 | 7.2 | 6.4 | ||||
| 1988 | 6.4 | 6.4 | 6.4 | 6.4 | ||||
| 1989 | 6.3 | 6.5 | 6.3 | 6.5 | ||||
| 1990 | 6.9 | 6.5 | 6.9 | 6.5 | ||||
| 1991 | 7.2 | 6.6 | 7.2 | 6.6 | ||||
| 1992 | 7.0 | 6.6 | 7.0 | 6.7 | 7.0 | 6.7 | 7.0 | 6.6 |
| 1993 | 6.8 | 6.7 | 6.8 | 6.7 | 6.8 | 6.8 | 6.8 | 6.7 |
| 1994 | 6.3 | 6.8 | 6.3 | 6.8 | 6.5 | 6.8 | 6.5 | 6.7 |
| 1995 | 6.8 | 6.8 | 6.8 | 6.8 | 6.6 | 6.9 | 6.6 | 6.8 |
| 1996 | 6.9 | 6.9 | 6.9 | 6.9 | 7.1 | 6.9 | 7.1 | 6.9 |
| 1997 | 7.1 | 6.9 | 7.1 | 7.0 | 7.1 | 6.9 | 7.1 | 6.9 |
| 1998 | 7.1 | 7.0 | 7.1 | 7.0 | 7.0 | 7.0 | 7.0 | 7.0 |
| 1999 | 6.6 | 7.1 | 6.6 | 7.1 | 6.6 | 7.0 | 6.6 | 7.0 |
| 2000 | 7.7 | 7.1 | 7.7 | 7.2 | 7.5 | 7.1 | 7.5 | 7.1 |
| 2001 | 6.9 | 7.2 | 6.9 | 7.2 | 6.8 | 7.1 | 6.8 | 7.1 |
| 2002 | 7.7 | 7.2 | 7.7 | 7.3 | 7.3 | 7.1 | 7.3 | 7.2 |
| 2003 | 7.2 | 7.3 | 7.2 | 7.4 | 7.2 | 7.2 | 7.2 | 7.3 |
| 2004 | 7.1 | 7.4 | 7.1 | 7.4 | 7.1 | 7.2 | 7.1 | 7.3 |
| 2005 | 7.6 | 7.4 | 7.6 | 7.5 | 7.4 | 7.3 | 7.4 | 7.4 |
| 2006 | 6.9 | 7.5 | 6.9 | 7.6 | 6.9 | 7.3 | 6.9 | 7.5 |
| 2007 | 7.8 | 7.6 | 7.8 | 7.6 | 7.7 | 7.5 | 7.6 | 7.5 |
| 2008 | 7.5 | 7.8 | 7.4 | 7.7 | 7.5 | 7.6 | 7.4 | 7.6 |
| 2009 | 8.0 | 7.9 | 7.8 | 7.8 | 8.0 | 7.8 | 7.8 | 7.6 |
| 2010 | 8.1 | 8.1 | 8.0 | 7.9 | 8.2 | 7.9 | 8.0 | 7.7 |
| 2011 | 8.3 | 8.3 | 8.1 | 7.9 | 8.1 | 8.1 | 7.9 | 7.8 |
| 2012 | 8.3 | 8.4 | 8.0 | 8.0 | 8.4 | 8.3 | 8.1 | 7.8 |
| 2013 | 8.9 | 8.6 | 8.4 | 8.1 | 8.6 | 8.4 | 8.2 | 7.9 |
| 2014 | 8.5 | 8.8 | 8.0 | 8.1 | 8.3 | 8.6 | 7.8 | 8.0 |
| 2015 | 9.0 | 8.9 | 8.2 | 8.2 | 8.6 | 8.8 | 7.8 | 8.0 |
Rates per 100,000 for Myeloma, Black, Male, All Ages
| Year | Delay-Adjusted SEER 9 Incidence 1975-2015 | Delay-Adjusted SEER 9 Incidence 1975-2015 Modeled (from Joinpoint) | Observed SEER 9 Incidence 1975-2015 | Observed SEER 9 Incidence 1975-2015 Modeled (from Joinpoint) | Delay-Adjusted SEER 13 Incidence 1992-2015 | Delay-Adjusted SEER 13 Incidence 1992-2015 Modeled (from Joinpoint) | Observed SEER 13 Incidence 1992-2015 | Observed SEER 13 Incidence 1992-2015 Modeled (from Joinpoint) |
|---|---|---|---|---|---|---|---|---|
| 1975 | 10.9 | 12.6 | 10.9 | 12.7 | ||||
| 1976 | 11.1 | 12.7 | 11.1 | 12.8 | ||||
| 1977 | 11.0 | 12.8 | 11.0 | 12.8 | ||||
| 1978 | 11.1 | 12.9 | 11.1 | 12.9 | ||||
| 1979 | 15.3 | 12.9 | 15.3 | 13.0 | ||||
| 1980 | 10.8 | 13.0 | 10.8 | 13.0 | ||||
| 1981 | 15.2 | 13.1 | 15.2 | 13.1 | ||||
| 1982 | 13.9 | 13.2 | 13.9 | 13.2 | ||||
| 1983 | 16.3 | 13.2 | 16.3 | 13.3 | ||||
| 1984 | 15.2 | 13.3 | 15.2 | 13.3 | ||||
| 1985 | 12.6 | 13.4 | 12.6 | 13.4 | ||||
| 1986 | 11.6 | 13.5 | 11.6 | 13.5 | ||||
| 1987 | 13.5 | 13.6 | 13.5 | 13.6 | ||||
| 1988 | 12.1 | 13.6 | 12.1 | 13.6 | ||||
| 1989 | 13.6 | 13.7 | 13.6 | 13.7 | ||||
| 1990 | 14.6 | 13.8 | 14.6 | 13.8 | ||||
| 1991 | 15.9 | 13.9 | 15.9 | 13.9 | ||||
| 1992 | 13.3 | 14.0 | 13.3 | 13.9 | 13.5 | 13.1 | 13.5 | 13.5 |
| 1993 | 15.7 | 14.0 | 15.7 | 14.0 | 15.1 | 13.3 | 15.1 | 13.7 |
| 1994 | 15.3 | 14.1 | 15.3 | 14.1 | 14.0 | 13.5 | 14.0 | 13.8 |
| 1995 | 15.2 | 14.2 | 15.2 | 14.2 | 13.2 | 13.7 | 13.2 | 13.9 |
| 1996 | 13.5 | 14.3 | 13.5 | 14.3 | 14.2 | 13.9 | 14.2 | 14.1 |
| 1997 | 14.4 | 14.4 | 14.4 | 14.3 | 14.3 | 14.1 | 14.3 | 14.2 |
| 1998 | 13.4 | 14.5 | 13.4 | 14.4 | 13.5 | 14.3 | 13.5 | 14.3 |
| 1999 | 15.5 | 14.6 | 15.5 | 14.5 | 15.6 | 14.5 | 15.6 | 14.5 |
| 2000 | 10.9 | 14.6 | 10.9 | 14.6 | 10.6 | 14.7 | 10.6 | 14.6 |
| 2001 | 15.2 | 14.7 | 15.2 | 14.7 | 14.9 | 14.9 | 14.9 | 14.8 |
| 2002 | 14.1 | 14.8 | 14.1 | 14.7 | 14.7 | 15.1 | 14.7 | 14.9 |
| 2003 | 14.2 | 14.9 | 14.2 | 14.8 | 15.0 | 15.3 | 15.0 | 15.1 |
| 2004 | 16.2 | 15.0 | 16.2 | 14.9 | 16.4 | 15.5 | 16.4 | 15.2 |
| 2005 | 14.7 | 15.1 | 14.7 | 15.0 | 14.5 | 15.7 | 14.5 | 15.3 |
| 2006 | 15.0 | 15.2 | 15.0 | 15.5 | 15.2 | 15.9 | 15.2 | 15.5 |
| 2007 | 15.0 | 15.3 | 14.9 | 16.0 | 15.4 | 16.2 | 15.3 | 15.7 |
| 2008 | 18.2 | 16.6 | 17.9 | 16.5 | 17.2 | 16.4 | 16.9 | 15.8 |
| 2009 | 17.3 | 18.0 | 16.9 | 17.0 | 16.2 | 16.6 | 15.8 | 16.0 |
| 2010 | 19.6 | 19.5 | 19.0 | 17.5 | 18.5 | 16.8 | 17.9 | 16.1 |
| 2011 | 17.3 | 18.9 | 16.6 | 18.1 | 17.4 | 17.1 | 16.7 | 16.3 |
| 2012 | 20.1 | 18.4 | 19.1 | 18.7 | 18.9 | 17.3 | 18.0 | 16.4 |
| 2013 | 17.9 | 17.8 | 16.8 | 17.2 | 18.1 | 17.5 | 16.9 | 16.6 |
| 2014 | 16.9 | 17.3 | 15.6 | 15.9 | 17.0 | 17.8 | 15.6 | 16.8 |
| 2015 | 16.7 | 16.8 | 15.0 | 14.7 | 17.0 | 18.0 | 15.2 | 16.9 |
Annual Percent Changes for the most recent trend in the data series as calculated by Joinpoint
Myeloma, Male, All Ages
| Data Series | Year Range for APC | APC |
|---|---|---|
| Delay-Adjusted SEER 9 Incidence, All Races, 1975-2015 | 2006-15 | 2.2* |
| Observed SEER 9 Incidence, All Races, 1975-2015 | 1975-15 | 0.9* |
| Delay-Adjusted SEER 13 Incidence, All Races, 1992-2015 | 2004-15 | 1.9* |
| Observed SEER 13 Incidence, All Races, 1992-2015 | 2010-15 | -0.5 |
| Delay-Adjusted SEER 9 Incidence, White, 1975-2015 | 2006-15 | 2.0* |
| Observed SEER 9 Incidence, White, 1975-2015 | 1975-15 | 0.9* |
| Delay-Adjusted SEER 13 Incidence, White, 1992-2015 | 2006-15 | 2.1* |
| Observed SEER 13 Incidence, White, 1992-2015 | 1992-15 | 0.8* |
| Delay-Adjusted SEER 9 Incidence, Black, 1975-2015 | 2010-15 | -2.9 |
| Observed SEER 9 Incidence, Black, 1975-2015 | 2012-15 | -7.7 |
| Delay-Adjusted SEER 13 Incidence, Black, 1992-2015 | 1992-15 | 1.4* |
| Observed SEER 13 Incidence, Black, 1992-2015 | 1992-15 | 1.0* |
Footnotes:
a Source: SEER 9 areas and SEER 13 areas. Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103).
Regression lines and APCs are calculated using the Joinpoint Regression Program Version 4.6, February 2018, National Cancer Institute.
The APC is the Annual Percent Change for the regression line segments.
* The APC is significantly different from zero (p < 0.05).
Page Navigation: << Previous Next >>
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.